Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)
CNY 20.17
(-0.93%)
CNY 20.17
(-0.93%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 112.57 Million CNY | 38.15% |
| 2022 | 81.49 Million CNY | 8.86% |
| 2021 | 74.85 Million CNY | 14.32% |
| 2020 | 65.47 Million CNY | -0.58% |
| 2019 | 65.85 Million CNY | -2.48% |
| 2018 | 67.53 Million CNY | -14.01% |
| 2017 | 78.53 Million CNY | -15.55% |
| 2016 | 92.99 Million CNY | 1.23% |
| 2015 | 91.86 Million CNY | 31.17% |
| 2014 | 70.03 Million CNY | 12.98% |
| 2013 | 61.98 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 107.44 Million CNY | -4.56% |
| 2024 Q2 | 107.67 Million CNY | 0.21% |
| 2024 Q3 | 131.2 Million CNY | 21.85% |
| 2023 Q3 | 116.18 Million CNY | -6.79% |
| 2023 Q1 | 115.58 Million CNY | 41.83% |
| 2023 Q4 | 112.57 Million CNY | -3.1% |
| 2023 FY | 112.57 Million CNY | 38.15% |
| 2023 Q2 | 124.64 Million CNY | 7.84% |
| 2022 Q3 | 83.97 Million CNY | 7.37% |
| 2022 FY | 81.49 Million CNY | 8.86% |
| 2022 Q1 | 75.25 Million CNY | 0.54% |
| 2022 Q4 | 81.49 Million CNY | -2.96% |
| 2022 Q2 | 78.21 Million CNY | 3.93% |
| 2021 FY | 74.85 Million CNY | 14.32% |
| 2021 Q4 | 74.85 Million CNY | -2.17% |
| 2021 Q3 | 76.51 Million CNY | -0.78% |
| 2021 Q2 | 77.11 Million CNY | 0.4% |
| 2021 Q1 | 76.8 Million CNY | 17.31% |
| 2020 Q3 | 68.4 Million CNY | 10.3% |
| 2020 Q4 | 65.47 Million CNY | -4.27% |
| 2020 Q1 | 63.6 Million CNY | -3.43% |
| 2020 FY | 65.47 Million CNY | -0.58% |
| 2020 Q2 | 62.01 Million CNY | -2.5% |
| 2019 Q2 | 74.95 Million CNY | 0.0% |
| 2019 Q3 | 78.96 Million CNY | 5.35% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 65.85 Million CNY | -2.48% |
| 2019 Q4 | 65.85 Million CNY | -16.6% |
| 2018 FY | 67.53 Million CNY | -14.01% |
| 2018 Q4 | 67.53 Million CNY | 0.0% |
| 2017 FY | 78.53 Million CNY | -15.55% |
| 2016 FY | 92.99 Million CNY | 1.23% |
| 2015 FY | 91.86 Million CNY | 31.17% |
| 2014 FY | 70.03 Million CNY | 12.98% |
| 2013 FY | 61.98 Million CNY | 0.0% |